N漢邦
688755
N澤潤新能
301636
森萱醫葯
830946
4
格力博
301260
5
拓新藥業
301089
(Q1)2025/03/31 | (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 6.01%1.67億 | 10.74%6.53億 | 8.82%1.69億 | 10.09%1.66億 | 11.02%1.61億 | 13.29%1.57億 | 12.82%5.9億 | 11.27%1.56億 | 12.24%1.51億 | 12.53%1.45億 |
營業收入 | 6.01%1.67億 | 10.74%6.53億 | 8.82%1.69億 | 10.09%1.66億 | 11.02%1.61億 | 13.29%1.57億 | 12.82%5.9億 | 11.27%1.56億 | 12.24%1.51億 | 12.53%1.45億 |
主營業務成本 | 4.67%4,092.4萬 | 10.34%1.62億 | 10.11%4,141.4萬 | 11.72%4,110.6萬 | 8.71%4,034.8萬 | 10.85%3,909.7萬 | 13.45%1.47億 | 12.74%3,761.2萬 | 13.47%3,679.4萬 | 12.74%3,711.6萬 |
毛利 | 6.46%1.26億 | 10.87%4.91億 | 8.41%1.28億 | 9.56%1.25億 | 11.82%1.2億 | 14.13%1.18億 | 12.62%4.43億 | 10.81%1.18億 | 11.85%1.14億 | 12.46%1.07億 |
營業費用 | 0.83%1.17億 | 12.74%4.71億 | 16.98%1.22億 | 9.18%1.16億 | 30.89%1.17億 | -1.56%1.16億 | -6.28%4.18億 | 4.70%1.04億 | -13.74%1.06億 | -17.41%8,940.3萬 |
銷售和管理費用 | 0.28%9,140.8萬 | 17.62%3.7億 | 19.22%9,724.9萬 | 13.61%9,043.5萬 | 45.85%9,130.1萬 | 0.28%9,115.7萬 | -6.63%3.15億 | 14.16%8,157.4萬 | -16.68%7,960.2萬 | -22.08%6,260.1萬 |
-銷售費用 | 3.19%6,306.3萬 | 2.14%2.48億 | 13.83%6,476.9萬 | 1.04%6,221.9萬 | -3.99%6,024.8萬 | -1.32%6,111.1萬 | -5.34%2.43億 | -14.17%5,689.8萬 | -4.59%6,157.6萬 | -4.93%6,274.9萬 |
-管理費用 | -5.66%2,834.5萬 | 70.27%1.22億 | 31.63%3,248萬 | 56.53%2,821.6萬 | 21,081.76%3,105.3萬 | 3.69%3,004.6萬 | -10.76%7,153萬 | 378.40%2,467.6萬 | -41.85%1,802.6萬 | -101.03%-14.8萬 |
研發費用 | 2.84%2,572.5萬 | -2.16%1.01億 | 8.90%2,458.8萬 | -4.02%2,564.9萬 | -4.03%2,572.1萬 | -7.71%2,501.5萬 | -5.22%1.03億 | -19.43%2,257.8萬 | -3.60%2,672.2萬 | -3.94%2,680.2萬 |
營業利潤 | 304.84%887.4萬 | -19.97%2,025.6萬 | -55.54%620.9萬 | 14.87%871.9萬 | -82.63%313.6萬 | 115.33%219.2萬 | 148.35%2,531.2萬 | 96.18%1,396.6萬 | 135.44%759萬 | 242.24%1,805.5萬 |
淨非營業利息收入(費用) | -54.14%637萬 | -11.07%4,105萬 | -48.45%687.6萬 | -33.76%830.7萬 | 8.16%1,197.6萬 | 50.83%1,389.1萬 | 425.33%4,616.1萬 | 103.54%1,333.8萬 | 331.70%1,254.1萬 | 4,191.47%1,107.2萬 |
利息收入 | -42.11%889.2萬 | -4.32%4,980.8萬 | -36.59%939.9萬 | -21.71%1,098.4萬 | 12.14%1,406.5萬 | 44.02%1,536萬 | 255.67%5,205.9萬 | 84.88%1,482.2萬 | 219.81%1,403萬 | 631.31%1,254.2萬 |
利息費用 | 71.68%252.2萬 | 48.49%875.8萬 | 70.01%252.3萬 | 79.79%267.7萬 | 42.11%208.9萬 | 0.96%146.9萬 | 0.82%589.8萬 | 1.37%148.4萬 | 0.47%148.9萬 | 0.89%147萬 |
其他淨收入(費用) | -1,093.47%-529.9萬 | 678.18%6,339.2萬 | 100.70%8,000 | 95.89%-35.6萬 | 47,643.70%6,418.4萬 | 56.21%-44.4萬 | -185.45%-1,096.4萬 | -115.1萬 | -866.4萬 | -13.5萬 |
特殊收入(費用) | -1,093.47%-529.9萬 | 678.18%6,339.2萬 | 100.70%8,000 | 95.89%-35.6萬 | 47,643.70%6,418.4萬 | 56.21%-44.4萬 | -185.45%-1,096.4萬 | 70.03%-115.1萬 | ---866.4萬 | ---13.5萬 |
-減:重組與併購 | 1,093.47%529.9萬 | -84.31%172萬 | -100.70%-8,000 | -95.89%35.6萬 | 587.41%92.8萬 | -56.21%44.4萬 | 185.45%1,096.4萬 | -70.03%115.1萬 | --866.4萬 | --13.5萬 |
-減:其他特殊費用 | ---- | ---6,511.2萬 | --0 | ---- | ---6,511.2萬 | ---- | ---- | ---- | ---- | ---- |
稅前利潤 | -36.41%994.5萬 | 106.08%1.25億 | -49.94%1,309.3萬 | 45.37%1,667萬 | 173.51%7,929.6萬 | 356.25%1,563.9萬 | 227.63%6,050.9萬 | 166.03%2,615.3萬 | 161.94%1,146.7萬 | 333.15%2,899.2萬 |
所得稅 | 437.51%467.1萬 | -3,070.14%-4,306.7萬 | -2,749.87%-5,037.4萬 | 204.79%210.1萬 | 368.36%433.7萬 | 38.38%86.9萬 | 110.72%145萬 | 384.58%190.1萬 | -523.00%-200.5萬 | 299.57%92.6萬 |
除稅後利潤 | -64.29%527.4萬 | 184.06%1.68億 | 161.70%6,346.7萬 | 8.14%1,456.9萬 | 167.08%7,495.9萬 | 319.43%1,477萬 | 274.26%5,905.9萬 | 130.99%2,425.2萬 | 170.95%1,347.2萬 | 334.45%2,806.6萬 |
持續經營利潤 | -64.29%527.4萬 | 184.06%1.68億 | 161.70%6,346.7萬 | 8.14%1,456.9萬 | 167.08%7,495.9萬 | 319.43%1,477萬 | 274.26%5,905.9萬 | 130.99%2,425.2萬 | 170.95%1,347.2萬 | 334.45%2,806.6萬 |
歸屬於少數股東的淨利潤 | -119.82%-78.1萬 | 5.86%659.1萬 | 222.95%705萬 | -272.30%-266.9萬 | 37.80%-173.1萬 | -25.32%394.1萬 | 238.36%622.6萬 | 371.18%218.3萬 | 50.24%154.9萬 | -113.09%-278.3萬 |
歸屬於母公司的淨利潤 | -44.09%605.5萬 | 205.06%1.61億 | 155.64%5,641.7萬 | 44.58%1,723.8萬 | 148.60%7,669萬 | 190.18%1,082.9萬 | 279.76%5,283.3萬 | 95.23%2,206.9萬 | 159.56%1,192.3萬 | 389.25%3,084.9萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | -44.09%605.5萬 | 205.06%1.61億 | 155.64%5,641.7萬 | 44.58%1,723.8萬 | 148.60%7,669萬 | 190.18%1,082.9萬 | 279.76%5,283.3萬 | 95.23%2,206.9萬 | 159.56%1,192.3萬 | 389.25%3,084.9萬 |
基本每股收益 | -44.44%0.1 | 197.70%2.59 | 150.00%0.9 | 40.00%0.28 | 143.14%1.24 | 190.00%0.18 | 277.55%0.87 | 89.47%0.36 | 158.82%0.2 | 383.33%0.51 |
稀釋每股收益 | -41.18%0.1 | 79.01%1.45 | 146.88%0.79 | 42.11%0.27 | -51.11%0.22 | 185.00%0.17 | 265.31%0.81 | 77.78%0.32 | 155.88%0.19 | 350.00%0.45 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- |